| Olivia Washinski, | |
|
5423 Killens Pond Rd, Felton, DE 19943-1901 | |
| (302) 284-3020 | |
| Not Available |
| Full Name | Olivia Washinski |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 5423 Killens Pond Rd, Felton, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831674753 | NPI | - | NPPES |
| L1-0042124 | Other | DE | STATE OF DELAWARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | L1-0042124 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Olivia Washinski, 5423 Killens Pond Rd, Felton, DE 19943-1901 Ph: () - | Olivia Washinski, 5423 Killens Pond Rd, Felton, DE 19943-1901 Ph: (302) 284-3020 |
News Archive
During pregnancy, mild infections in the mother can have permanent and tissue-specific impacts on offspring immunity, according to a new study in mice.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today presented results from the follow-up phase of the initial clinical trial of its Neovasc Reducer(TM) product at the American College of Cardiology 2010 annual meeting. The Neovasc Reducer is a novel implantable product designed to treat heart disease patients who suffer from refractory angina. The new data shows that three years after implantation of the Reducer, the majority of patients continued to show measurable improvement in angina symptoms.
In a study recently published in the journal Nature Communications, scientists have mapped the interactions between SARS-CoV-2 RNA and host RNA. They have observed that the virus heavily methylates its genome using the methylation machinery of the host RNA, leading to an improvement in viral fitness.
› Verified 7 days ago
Virginia Marie Serrano, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 545 Indian Point Rd, Felton, DE 19943 Phone: 302-359-8503 | |
Jean Callaway, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5423 Killens Pond Rd, Felton, DE 19943 Phone: 302-284-3020 | |
Christina Roberts, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5423 Killens Pond Rd, Felton, DE 19943 Phone: 302-284-5810 | |
John Rocks, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 172 Charlies Ct, Felton, DE 19943 Phone: 302-222-8626 | |
Jessica K. Everett, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 55 Hackberry Drive, Felton, DE 19943 Phone: 302-222-4577 | |
Allison Tatman, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5423 Killens Pond Rd, Felton, DE 19943 Phone: 302-284-3020 | |
Nataleen Villabona, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3227 Little Mastens Corner Rd, Felton, DE 19943 Phone: 302-382-3004 |